Foray Bioscience
PrivateLast Round
Seed
Jun 25, 2024
Total Funding Raised
$3.88M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Foray Bioscience operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in June 2024.
Foray Bioscience is a biotechnology company that develops plant cell culture and biomanufacturing technologies to produce harvest-free plant-based materials, molecules, and seeds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Vertical SaaS, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Foray Bioscience Comparables
Compare Foray Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ayana Bio | 66% | |
| Benchling | 62% | |
| DFB Pharmaceuticals | 60% |
For institutional investors. Book with your work email.
Foray Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 25, 2024 | ||||
| Pre Seed | Jul 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Foray Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Engine | Seed |
| Engine Ventures | Seed |
| Susquehanna Sustainable Investments | Seed |
| Understorey Ventures | Seed |
| Regenerative Ventures Holdings | Seed |
| U.S. Department of Agriculture | Pre Seed |
| Superorganism | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 419% MoM, reaching 4.4K.
- Jul 17, 2026
Grew 18% QoQ, from 17 to 20 employees.
For institutional investors. Book with your work email.
Foray Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Foray Bioscience's valuation, stock price, and market status.
Is Foray Bioscience a public or private company?
Foray Bioscience is a private company.
What is the current stock price of Foray Bioscience?
Foray Bioscience is a private company, so its shares have no public market price. Caplight tracks Foray Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Foray Bioscience worth (valuation)?
Valuation information for Foray Bioscience is not publicly available.
Can I buy Foray Bioscience stock?
Foray Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Foray Bioscience's last funding round?
Foray Bioscience's most recent funding round was Seed on June 25, 2024.
Who are the main investors in Foray Bioscience?
Key investors in Foray Bioscience include Regenerative Ventures Holdings, ReGen Ventures.
Will Foray Bioscience IPO soon?
No public IPO plans have been announced for Foray Bioscience.
How can I track Foray Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Foray Bioscience's shares on secondary markets.